(19)
(11) EP 2 120 958 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.05.2013 Bulletin 2013/20

(45) Mention of the grant of the patent:
20.03.2013 Bulletin 2013/12

(21) Application number: 07868993.2

(22) Date of filing: 05.12.2007
(51) International Patent Classification (IPC): 
A61K 31/535(2006.01)
A61P 35/00(2006.01)
 C07D 211/00(2006.01)
(86) International application number:
PCT/US2007/086453
(87) International publication number:
WO 2008/070697 (12.06.2008 Gazette 2008/24)

(54)

STAT3 INHIBITOR HAVING ANTI-CANCER ACTIVITY AND ASSOCIATED METHODS

STAT3-INHIBITOR MIT ANTI-KREBS-AKTIVITÄT UND ZUGEHÖRIGE VERFAHREN

INHIBITEUR DE STAT3 AYANT UNE ACTIVITÉ ANTICANCÉREUSE ET PROCÉDÉS ASSOCIÉS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 06.12.2006 US 868794 P

(43) Date of publication of application:
25.11.2009 Bulletin 2009/48

(73) Proprietors:
  • University of Central Florida Research Foundation, Inc.
    Orlando, FL 32826 (US)
  • Yale University
    New Haven, CT 06511 (US)
  • University of South Florida
    Tampa, FL 33612 (US)

(72) Inventors:
  • TURKSON, James
    Orlando, FL 32829 (US)
  • HAMILTON, Andrew D.
    New Haven, CT 06520-8107 (US)
  • JOVE, Richard
    Glendora, CA 91741 (US)
  • SEBTI, Said M.
    Tampa, FL 33647 (US)

(74) Representative: Warner, James Alexander et al
Carpmaels & Ransford One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2006/091837
 US-A1- 2008 045 528
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).